Morning, Wednesday, 13th March 2019
THIS EVENT IS CPD CERTIFIED
This conference will be a timely opportunity to discuss the next steps for health research in England - looking at funding, regulation and policy.
Planned sessions will consider priorities for utilising Government funding for NHS health research in light of the recent publication on NHS England’s Long Term Plan, which looks at prevention, earlier diagnosis, the role of genomics and the impact of research and development on the UK economy.
Delegates will discuss the progress of the Life Sciences Council following the release of the second Life Sciences Sector Deal - which looks to strengthen the role of the life sciences sector in transforming the prevention, diagnosis and treatment of chronic diseases - as well as the key issues for collaboration and the regulation of clinical trials following Brexit.
They will also assess the impact of the Industrial Strategy Challenge Fund in supporting the growth of the life sciences sector - with the new Life Sciences Sector Deal citing over £1.3bn in investment from the private sector - and the way forward for improving collaboration on innovation and sharing data, looking at the progress of the new Health Data Research Alliance as it seeks to bring together datasets from across the NHS.
Further sessions will focus on additional opportunities for supporting public and patient involvement in healthcare research as Government and industry aim to study 5m healthy people to develop new diagnostic tests and improve detection of deadly diseases.